Galantamine Slows Down Plaque Formation and Behavioral Decline in the 5XFAD Mouse Model of Alzheimer’s Disease

Open Access

Peer-reviewed

Research Article

Soumee Bhattacharya,

Affiliation Neurogenetics Special Laboratory, Leibniz Institute for Neurobiology, Magdeburg, Germany
⨯
Christin Haertel,

Affiliation Neurogenetics Special Laboratory, Leibniz Institute for Neurobiology, Magdeburg, Germany
⨯
Alfred Maelicke,

Affiliation Galantos Pharma GmbH, Nieder-Olm, Germany
⨯
Dirk Montag

* E-mail: montag@LIN-magdeburg.de

Affiliation Neurogenetics Special Laboratory, Leibniz Institute for Neurobiology, Magdeburg, Germany
⨯

Reader Comments (0)

Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Genetically modified animals
Is the Subject Area "Genetically modified animals" applicable to this article?

Thanks for your feedback.
Animal behavior
Is the Subject Area "Animal behavior" applicable to this article?

Thanks for your feedback.
Alzheimer's disease
Is the Subject Area "Alzheimer's disease" applicable to this article?

Thanks for your feedback.
Hippocampus
Is the Subject Area "Hippocampus" applicable to this article?

Thanks for your feedback.
Astrocytes
Is the Subject Area "Astrocytes" applicable to this article?

Thanks for your feedback.
Mice
Is the Subject Area "Mice" applicable to this article?

Thanks for your feedback.
Entorhinal cortex
Is the Subject Area "Entorhinal cortex" applicable to this article?

Thanks for your feedback.